Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Positief advies sluisplaatsing ublituximab en mirikizumab
mei 2023 | IBD, Multipele Sclerose